From October 1, 2022 to December 15, 2022, the company has repurchased 394,400 shares, representing 0.11% for CNY 9.28 million. With this, the company has completed the repurchase of 2,403,643 shares, representing 0.69% for CNY 58 million under the buyback announced on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.74 CNY | +0.60% |
|
+2.64% | -22.89% |
May. 31 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Dividend Implementation for 2023, Payable on 06 June 2024 | CI |
May. 06 | China Approves Tianyu Pharma's Heart Medication | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.89% | 793M | |
+26.58% | 45.33B | |
+38.49% | 25.36B | |
+27.75% | 16.7B | |
+20.89% | 14.59B | |
+72.03% | 14.26B | |
-0.05% | 6.79B | |
-10.35% | 6.67B | |
+13.07% | 5.62B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 30, 2022.